• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adrenal Insufficiency after Long-term use of Topical Glucocorticoids in Patients with Advanced Cutaneous T-cell Lymphomas: A Case Series.

作者信息

Glutsch Valerie, Schummer Patrick, Koschker Ann-Cathrin, Goebeler Matthias, Wobser Marion

机构信息

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

Endocrinology and Diabetes Unit, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.

出版信息

Acta Derm Venereol. 2024 Apr 2;104:adv19672. doi: 10.2340/actadv.v104.19672.

DOI:10.2340/actadv.v104.19672
PMID:38566532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11000654/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49c/11000654/26859b199824/ActaDV-104-19672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49c/11000654/26859b199824/ActaDV-104-19672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d49c/11000654/26859b199824/ActaDV-104-19672-g001.jpg

相似文献

1
Adrenal Insufficiency after Long-term use of Topical Glucocorticoids in Patients with Advanced Cutaneous T-cell Lymphomas: A Case Series.晚期皮肤T细胞淋巴瘤患者长期使用外用糖皮质激素后发生肾上腺皮质功能不全：病例系列
Acta Derm Venereol. 2024 Apr 2;104:adv19672. doi: 10.2340/actadv.v104.19672.
2
[Symptomatic adrenal insufficiency secondary to the use of cutaneous topical steroids for skin-bleaching].因使用皮肤外用类固醇进行皮肤美白继发的症状性肾上腺皮质功能不全
Rev Med Interne. 2008 Dec;29(12):1030-3. doi: 10.1016/j.revmed.2008.02.014. Epub 2008 Jun 30.
3
A case series of cutaneous lymphomas in Mexico.墨西哥皮肤淋巴瘤病例系列。
Bol Med Hosp Infant Mex. 2020;77(2):90-93. doi: 10.24875/BMHIM.19000126.
4
[Cutaneous lymphomas].[皮肤淋巴瘤]
Ther Umsch. 2010 Sep;67(9):453-64. doi: 10.1024/0040-5930/a000079.
5
[Cutaneous lymphoma].[皮肤淋巴瘤]
Hautarzt. 2004 Oct;55(10):1005-16; quiz 1017. doi: 10.1007/s00105-004-0816-2.
6
Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas.血管瘤患儿全身糖皮质激素治疗后肾上腺皮质功能减退的患病率
Arch Dermatol. 2009 Mar;145(3):262-6. doi: 10.1001/archdermatol.2008.572.
7
The Potential for Teledermatology in Managing and Diagnosing Patients With Cutaneous Lymphomas.远程皮肤病学在皮肤淋巴瘤患者管理和诊断中的潜力
J Drugs Dermatol. 2020 Nov 1;19(11):1125. doi: 10.36849/JDD.2020.5682.
8
Adrenal insufficiency.肾上腺功能不全
N Engl J Med. 1997 Apr 10;336(15):1105; author reply 1106-7. doi: 10.1056/NEJM199704103361516.
9
Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.采用免疫反应调节剂咪喹莫特局部应用治疗IA期皮肤T细胞淋巴瘤。
Arch Dermatol. 2002 Sep;138(9):1137-9. doi: 10.1001/archderm.138.9.1137.
10
Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas.度普利尤单抗治疗两名皮肤T细胞淋巴瘤患者
Acta Derm Venereol. 2020 Sep 30;100(16):adv00271. doi: 10.2340/00015555-3576.

本文引用的文献

1
S2k-Guidelines - Cutaneous lymphomas (ICD10 C82 - C86): Update 2021.S2k指南 - 皮肤淋巴瘤（ICD10 C82 - C86）：2021年更新
J Dtsch Dermatol Ges. 2022 Apr;20(4):537-554. doi: 10.1111/ddg.14706.
2
Topical corticosteroids and risk of diabetes mellitus: systematic review and meta-analysis.外用糖皮质激素与糖尿病风险：系统评价与荟萃分析
J Dermatolog Treat. 2021 May;32(3):345-349. doi: 10.1080/09546634.2019.1657224. Epub 2019 Aug 25.
3
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas.2018 年版 WHO-EORTC 原发性皮肤淋巴瘤分类。
Blood. 2019 Apr 18;133(16):1703-1714. doi: 10.1182/blood-2018-11-881268. Epub 2019 Jan 11.
4
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.莫格利珠单抗对比伏立诺他治疗既往治疗的皮肤 T 细胞淋巴瘤（MAVORIC）：一项国际性、开放性标签、随机、对照的 3 期临床试验。
Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9.
5
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.本妥昔单抗维达妥或医师选择治疗 CD30 阳性皮肤 T 细胞淋巴瘤（ALCANZA）：一项国际性、开放性标签、随机、3 期、多中心试验。
Lancet. 2017 Aug 5;390(10094):555-566. doi: 10.1016/S0140-6736(17)31266-7. Epub 2017 Jun 7.
6
Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events.免疫检查点抑制剂：内分泌不良事件的综述与管理
Oncologist. 2016 Jul;21(7):804-16. doi: 10.1634/theoncologist.2015-0509. Epub 2016 Jun 15.
7
Skin-Directed Therapies in Cutaneous T-Cell Lymphoma.皮肤定向疗法治疗皮肤T细胞淋巴瘤
Dermatol Clin. 2015 Oct;33(4):683-96. doi: 10.1016/j.det.2015.05.004. Epub 2015 Aug 10.
8
Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.长期滥用外用糖皮质激素导致的肾上腺功能不全。
Dermatology. 2014;228(4):289-93. doi: 10.1159/000358427. Epub 2014 Apr 15.
9
Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.因局部皮质类固醇应用引起的外源性库欣综合征：病例报告及文献复习。
Endocrine. 2010 Dec;38(3):328-34. doi: 10.1007/s12020-010-9393-6. Epub 2010 Oct 23.
10
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).蕈样肉芽肿和塞扎里综合征分期与分类的修订：国际皮肤淋巴瘤协会（ISCL）和欧洲癌症研究与治疗组织（EORTC）皮肤淋巴瘤特别工作组的提议
Blood. 2007 Sep 15;110(6):1713-22. doi: 10.1182/blood-2007-03-055749. Epub 2007 May 31.